NO20030523D0 - Polymorphs of zaleplon and processes for their preparation - Google Patents
Polymorphs of zaleplon and processes for their preparationInfo
- Publication number
- NO20030523D0 NO20030523D0 NO20030523A NO20030523A NO20030523D0 NO 20030523 D0 NO20030523 D0 NO 20030523D0 NO 20030523 A NO20030523 A NO 20030523A NO 20030523 A NO20030523 A NO 20030523A NO 20030523 D0 NO20030523 D0 NO 20030523D0
- Authority
- NO
- Norway
- Prior art keywords
- zaleplon
- polymorphs
- processes
- preparation
- Prior art date
Links
- HUNXMJYCHXQEGX-UHFFFAOYSA-N zaleplon Chemical compound CCN(C(C)=O)C1=CC=CC(C=2N3N=CC(=C3N=CC=2)C#N)=C1 HUNXMJYCHXQEGX-UHFFFAOYSA-N 0.000 title 1
- 229960004010 zaleplon Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22278500P | 2000-08-03 | 2000-08-03 | |
PCT/US2001/024510 WO2002012244A2 (en) | 2000-08-03 | 2001-08-02 | Polymorphs of zaleplon and methods for the preparation thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20030523D0 true NO20030523D0 (en) | 2003-02-03 |
NO20030523L NO20030523L (en) | 2003-03-11 |
Family
ID=22833666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20030523A NO20030523L (en) | 2000-08-03 | 2003-02-03 | Polymorphs of zaleplon and processes for their preparation |
Country Status (18)
Country | Link |
---|---|
US (2) | US20020072527A1 (en) |
EP (1) | EP1305315A2 (en) |
JP (1) | JP2004505979A (en) |
KR (2) | KR20030036659A (en) |
CN (2) | CN1847244A (en) |
AR (1) | AR036324A1 (en) |
AU (2) | AU2001283119B2 (en) |
BR (1) | BR0113244A (en) |
CA (1) | CA2417875C (en) |
HU (1) | HUP0303055A3 (en) |
IL (1) | IL154088A0 (en) |
MX (1) | MXPA03001048A (en) |
NO (1) | NO20030523L (en) |
NZ (1) | NZ527455A (en) |
PL (1) | PL365678A1 (en) |
SG (1) | SG125971A1 (en) |
WO (1) | WO2002012244A2 (en) |
ZA (1) | ZA200300779B (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005507858A (en) * | 2001-06-12 | 2005-03-24 | ビオガル ジョジセルジャール アール テー. | How to produce zaleplon |
US20050032818A1 (en) * | 2001-06-12 | 2005-02-10 | Entire Interest | N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-5-yl)phenyl]-N-ethylacetamide and crystalline forms of zaleplon |
HUP0402253A3 (en) | 2001-08-01 | 2005-12-28 | Teva Gyogyszergyar Zartkoeruee | Process for the purification of n-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)-phenyl]-n-ethylacetamide(zaleplon) and the preparation of its novel crystalline forms and pharmaceutical compositions containing the latters |
PL373694A1 (en) * | 2002-02-15 | 2005-09-05 | Teva Gyogyszergyar Reszvenytarsasag | Powder composition comprising zaleplon of defined particle size distribution and pharmaceutical products made therefrom |
WO2004035585A1 (en) * | 2002-10-16 | 2004-04-29 | Sanmar Speciality Chemicals Limited | Synthesis of zaleplon |
DE112004001615T5 (en) * | 2003-09-04 | 2006-06-14 | Cipla Ltd. | Zaleplon synthesis |
US20070098788A1 (en) * | 2005-10-28 | 2007-05-03 | Gore Subhash P | Non-benzodiazepine hypnotic compositions |
EP1956021A1 (en) * | 2006-10-11 | 2008-08-13 | Ferrer Internacional, S.A. | Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound |
EP2370136A4 (en) * | 2008-12-01 | 2015-12-30 | Map Pharmaceuticals Inc | Inhalation delivery methods and devices |
WO2010074753A1 (en) | 2008-12-23 | 2010-07-01 | Map Pharmaceuticals, Inc. | Inhalation devices and related methods for administration of sedative hypnotic compounds |
CN102816163A (en) * | 2012-08-20 | 2012-12-12 | 四川禾邦阳光制药股份有限公司 | New crystal form of zaleplon, and preparation method thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4626538A (en) * | 1983-06-23 | 1986-12-02 | American Cyanamid Company | [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines |
KR0167261B1 (en) * | 1995-10-19 | 1999-04-15 | 문정환 | The control circuit for power supply |
US5714607A (en) * | 1995-12-01 | 1998-02-03 | American Cyanamid Company | Process improvement in the synthesis of N- 3-(3-cyano-pyrazolo 1,5-a!pyrimidin-7-yl)phenyl!-N-ethylacetamide |
AR029780A1 (en) * | 2000-12-13 | 2003-07-16 | Gador Sa | IMPROVED PROCEDURE FOR OBTAINING N- [3 (3-CIANO-PIRAZOLO [1,5-A] PIRIMIDIN-7-IL) PHENYL] -N-ETIL-ACETAMIDE |
HUP0402253A3 (en) * | 2001-08-01 | 2005-12-28 | Teva Gyogyszergyar Zartkoeruee | Process for the purification of n-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)-phenyl]-n-ethylacetamide(zaleplon) and the preparation of its novel crystalline forms and pharmaceutical compositions containing the latters |
-
2001
- 2001-08-02 CA CA002417875A patent/CA2417875C/en not_active Expired - Fee Related
- 2001-08-02 BR BR0113244-0A patent/BR0113244A/en not_active IP Right Cessation
- 2001-08-02 WO PCT/US2001/024510 patent/WO2002012244A2/en active IP Right Grant
- 2001-08-02 JP JP2002518219A patent/JP2004505979A/en active Pending
- 2001-08-02 EP EP01961891A patent/EP1305315A2/en not_active Withdrawn
- 2001-08-02 PL PL01365678A patent/PL365678A1/en not_active Application Discontinuation
- 2001-08-02 HU HU0303055A patent/HUP0303055A3/en unknown
- 2001-08-02 MX MXPA03001048A patent/MXPA03001048A/en not_active Application Discontinuation
- 2001-08-02 IL IL15408801A patent/IL154088A0/en unknown
- 2001-08-02 SG SG200500627A patent/SG125971A1/en unknown
- 2001-08-02 NZ NZ527455A patent/NZ527455A/en unknown
- 2001-08-02 CN CNA2006100802084A patent/CN1847244A/en active Pending
- 2001-08-02 KR KR10-2003-7001399A patent/KR20030036659A/en active Search and Examination
- 2001-08-02 KR KR1020077015099A patent/KR20070086867A/en not_active Application Discontinuation
- 2001-08-02 AU AU2001283119A patent/AU2001283119B2/en not_active Ceased
- 2001-08-02 AU AU8311901A patent/AU8311901A/en active Pending
- 2001-08-02 US US09/921,017 patent/US20020072527A1/en not_active Abandoned
- 2001-08-02 CN CNA018148565A patent/CN1610682A/en active Pending
- 2001-08-03 AR ARP010103740A patent/AR036324A1/en unknown
-
2003
- 2003-01-29 ZA ZA200300779A patent/ZA200300779B/en unknown
- 2003-02-03 NO NO20030523A patent/NO20030523L/en not_active Application Discontinuation
-
2004
- 2004-08-23 US US10/924,436 patent/US20050176735A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN1610682A (en) | 2005-04-27 |
SG125971A1 (en) | 2006-10-30 |
HUP0303055A2 (en) | 2004-01-28 |
US20050176735A1 (en) | 2005-08-11 |
PL365678A1 (en) | 2005-01-10 |
KR20030036659A (en) | 2003-05-09 |
MXPA03001048A (en) | 2004-02-26 |
KR20070086867A (en) | 2007-08-27 |
NZ527455A (en) | 2005-07-29 |
AU8311901A (en) | 2002-02-18 |
WO2002012244A2 (en) | 2002-02-14 |
AR036324A1 (en) | 2004-09-01 |
BR0113244A (en) | 2003-07-08 |
AU2001283119B2 (en) | 2007-11-15 |
HUP0303055A3 (en) | 2004-11-29 |
US20020072527A1 (en) | 2002-06-13 |
CA2417875A1 (en) | 2002-02-14 |
IL154088A0 (en) | 2003-07-31 |
ZA200300779B (en) | 2003-08-22 |
NO20030523L (en) | 2003-03-11 |
EP1305315A2 (en) | 2003-05-02 |
CA2417875C (en) | 2008-12-09 |
WO2002012244A3 (en) | 2002-06-13 |
CN1847244A (en) | 2006-10-18 |
JP2004505979A (en) | 2004-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20001648D0 (en) | Methods and intermediates for the preparation of anti-cancer compounds | |
NO20030844D0 (en) | Process for the preparation of N-aryl-anthranilic acids and derivatives thereof | |
NO20044533D0 (en) | Process for Preparation of 7-Substituted 3-Quinoline and 3-Quinol-4-Oncarbonitriles | |
NO20030707L (en) | Polymorphs of an epothilone analog | |
CY2013011I1 (en) | METHOD OF ADMINISTRATION OF DIPHOSPHONICS | |
NO20042680L (en) | Processes for the preparation of O-demethylvenflaxine | |
NO20021412L (en) | Soy milk mixtures and methods of preparation | |
NO20022176D0 (en) | Absorbent article and process for its preparation | |
NO20032332L (en) | Benzodiazepine derivative compounds, method of preparation and use thereof | |
NO20015542D0 (en) | Process for the preparation and use of N-desmethylzopiclones | |
NO20011026D0 (en) | Foodstuffs and methods of manufacture thereof | |
DK1328538T3 (en) | Process and intermediates for the preparation of 7-substituted antiestrogens | |
NO20020622L (en) | Polymorphs of torsemide | |
NO20030523D0 (en) | Polymorphs of zaleplon and processes for their preparation | |
NO20021124D0 (en) | Process for the preparation of benzoxazine derivatives and intermediates therefore | |
NO20035538D0 (en) | Process for the preparation of zaleplon | |
NO20040887L (en) | Purification and crystalline forms of zaleplon. | |
NO20003555L (en) | Process for the preparation of structural elements and the resulting elements | |
NO20024413L (en) | Process for making and using microgroups of biological materials | |
NO20030515D0 (en) | Process for the preparation of dinapsoline | |
NO20033743D0 (en) | Process and preparation of citalopram | |
EE200200410A (en) | Process for the Preparation of Acetylamidinophenylalanylcyclohexylglycylpyridinylalaninamides and Starting and Intermediate Compounds | |
NO20023702L (en) | Process for the preparation of 5-arylnicotinaldehydes | |
NO20035668D0 (en) | Anti-tumor formulations of thioxanthenone | |
EE200200053A (en) | Process of preparation of isoretinoin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |